Friday 6 November 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue: +19.2%
EPS: +64.1%
Free cash flow: −29.8%
Total debt: −5.19%

Quarter to September 2026, against a year earlier

146.38 9.74 −6.24%

Follow PODD

Alert me

Market cap: $10.8B
P/E: 25.2×
Fwd P/E: 24.4×
Dividend yield: —
F-score: 6/9
Altman Z: 9.09
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Insulet Corporation 10-Q filed Nov 4, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed Nov 4, 2026 · accepted 4:05 PM ET · Document on sec.gov · Filing index

Red flags

Receivables outpacing revenue Nov 4, 2026
Receivables grew 49.1% while revenue grew 19.2% year over year

10-Q filed Nov 4, 2026 · The filing · sec.gov

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Nov 6, 2025: 27 added · 28 removed · 45 modified; 2 with only figures updated; 1 moved without change

Insulet Corporation 10-Q filed Nov 4, 2026

Red flags

What changed

Stockrow Weekly